Researchers are continuing to study how hemp-derived cannabinoids interact with cellular stress and inflammation pathways. In the study “Metabolic responses of three distinct melanoma cell lines to UVA radiation and cannabigerol,” scientists examined how cannabigerol (CBG) affected melanoma cells exposed to UVA radiation. The research focused on oxidative stress, inflammation, and metabolic signaling pathways that may contribute to cellular damage and disease progression. (Life Science Network)

The findings showed that CBG helped reduce markers of oxidative stress and inflammation in several melanoma cell lines after UVA exposure. Researchers observed reductions in reactive oxygen species (ROS) and changes in signaling pathways connected to inflammation, antioxidant activity, and cellular stress response. The study also found that CBG influenced pathways associated with NF-κB, TNF-α, and Nrf2, which are important regulators of inflammation and oxidative balance within cells. (Life Science Network)

Scientists noted that CBG’s effects varied depending on the specific melanoma cell type being studied, highlighting the complexity of cannabinoid interactions within the body. While this research remains preclinical and additional human studies are still needed, studies like this continue expanding scientific understanding of how cannabinoids may interact with inflammation, oxidative stress, and cellular wellness pathways throughout the body. (Life Science Network)

Source

Jarocka-Karpowicz I, Gęgotek A, Atalay Ekiner S, et al. Metabolic responses of three distinct melanoma cell lines to UVA radiation and cannabigerol. Free Radical Biology and Medicine. Published April 3, 2026. (Life Science Network) https://pubmed.ncbi.nlm.nih.gov/41936916/